These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2858917)

  • 1. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs.
    Tran VT; Beal MF; Martin JB
    Science; 1985 Apr; 228(4698):492-5. PubMed ID: 2858917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of receptors for somatostatin in various tumors using different analogs.
    Srkalovic G; Cai RZ; Schally AV
    J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New specific radioligand for one subpopulation of brain somatostatin receptors.
    Reubi JC
    Life Sci; 1985 May; 36(19):1829-36. PubMed ID: 2859510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogs: correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells.
    Taparel D; Susini C; Esteve JP; Diaz J; Cazaubon C; Vaysse N; Ribet A
    Peptides; 1985; 6(1):109-14. PubMed ID: 2859571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
    Raynor K; Reisine T
    J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pituitary membrane receptors for somatostatin in the rat.
    Srikant CB; Patel YC
    Endocrinology; 1982 Jun; 110(6):2138-44. PubMed ID: 6122562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin cyclic octapeptide analogs which preferentially bind to SOMa receptors block a calcium current in rat superior cervical ganglion neurons.
    Ikeda SR; Schofield GG
    Neurosci Lett; 1989 Jan; 96(3):283-8. PubMed ID: 2566139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.
    Kao YJ; Ghosh M; Schonbrunn A
    Mol Endocrinol; 2011 Jun; 25(6):1040-54. PubMed ID: 21493671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain.
    Srikant CB; Coy DH; Patel YC
    Life Sci; 1983 Jul; 33(2):201-6. PubMed ID: 6135131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain somatostatin receptor subpopulation visualized by autoradiography.
    Maurer R; Reubi JC
    Brain Res; 1985 Apr; 333(1):178-81. PubMed ID: 2986771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs. Dissociation of brain receptor binding affinities and pituitary actions in the rat.
    Srikant CB; Patel YC
    Endocrinology; 1981 Jan; 108(1):341-3. PubMed ID: 6109622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of novel somatostatin antagonists.
    Bass RT; Buckwalter BL; Patel BP; Pausch MH; Price LA; Strnad J; Hadcock JR
    Mol Pharmacol; 1996 Oct; 50(4):709-15. PubMed ID: 8863814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
    Heiman ML; Murphy WA; Coy DH
    Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G; Locatelli V
    Endocrine; 2001 Feb; 14(1):29-33. PubMed ID: 11322499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.